A Goldman Sachs economist has suggested that the US economy could experience accelerated growth with increased use of GLP-1 ...

The headline trial results will be closely monitored by pharmaceutical industry experts. Shares in Novo Nordisk, which ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

FDA has not approved any generic versions of semaglutide." Eli Lilly, makers of Mounjaro and Zepbound, also used for weight loss, told CBS News: "Lilly has taken steps to help inform people about the ...

It seems like every day a new study emerges linking Ozempic and similar drugs to new health benefits. Ozempic is part of a drug class known as GLP-1 medications, which mimic gut hormones that help ...

Here are the key points about Viking Therapeutics' oral obesity drug VK2735: Early-Stage Trial Results: All doses of VK2735 ...

Viking Therapeutics' weight loss drug VK2735 may challenge Novo Nordisk and Eli Lilly's dominance in the obesity drug space ...

Shares of Viking Therapeutics (NASDAQ:VKTX) jumped 22% Monday morning after the biotech firm reported promising results for its experimental obesity pill ... similar to Eli Lilly's (LLY ...

Most of us are aware of the concept of drug side effects, which can be either negative or positive. The goal of any drug ...

We’ve tried Skinny Girl, and we can attest that it’s a high-quality diet pill on the market today. The lipogenic blend helps curb your appetite and supports a healthy lifestyle. The ...

Plot twist: These trendy weight loss medications aren’t like your regular pills. Many require specific ... Big pharma is finally reading the room. Eli Lilly recently announced a game-changing ...